trial

A Positron Emission Tomography Study of SLV354 in Healthy Subjects and Subjects With Schizophrenia

NCTId NCT01545310
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 1 · Completed
Enrollment 18 (actual)
Sponsored by Abbott Medical Devices
Primary completion 2012-07
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 1
Status
Completed
Enrollment
18 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2011-05
Primary completion
2012-07
Eligibility
MALE · 18 Years · 55 Years

Interventions & indications

Drugs
SLV354

Sponsors

Abbott Medical DevicesLead Sponsor

Investigators

1
Earle Bain, MDStudy Director

Sites

1 total
New Haven, United States

Facts & assertions

4 sourced
Enrollment
18
Phase
PHASE1
Primary Completion Date
2012-07
Status
COMPLETED
relationships
The graph out of here
drug
SLV354
drug
lead_sponsor
Abbott Medical Devices
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Earle Bain, MD
person